维普中文期刊产品整合服务
15篇 您的检索式:作者名="PENNINGTON WR"
    题名 作者 年代 出处 被引量
1Effects of age on plasma matrix metalloproteinases(MMPs)and tissue inhibitor of metalloproteinases(TIMPs)显示文摘Bonnema DD Webb CS Pennington WR 2007Card Fail2007,13,:1
2Matrix metalloproteinases/tissue inhibitors of metalloproteinases:relationship between changes in proteolytic determinants of matrix composition and structural,functional,and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
3Matrix metalloproteinases/tissue inhibitors of metalloproteinases:relationship between changes in proteolytic determinants of matrix composition and structural,functional,and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 0,,17:1
4Matrix metallopro- teinases/tissue inhibitors of metalloproteinases: relationship be- tween changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hyper- tensive heart disease 显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
5Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs)显示文摘BONNEMA DD WEBB CS PENNINGTON WR 2007J Card Fail2007,13,7:1
6Matrix Metalloprotein- ases/Tissue Inhibitors of Metalloproteinases Relationship between Changes in Proteolytic Determinants of Matrix Composition and Structura, 1 Functiona, 1 and Clinical Manifesta - tions of Hyperten- sive Heart Disease 显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,:1
7Matrix metalloproteinases/tissue inhibitors of metaUoproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease显示文摘AHMED SH CLARK LL PENNINGTON WR 2006Circulation2006,113,:1
8Effects of age on plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) 显示文摘Bnnnema DD Webb CS Pennington WR 2007J Card Fail2007,13,7:1
9Matrix metallopmtei- nases/tissue inhibitors of metallopmteinases: relationship between changes in proteolytic determinants of matrix composition and struc- tural, functional, and clinical manifestations of hypertensive heart disease 显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
10Matrix metalloproteinases/ tissue inhibitors of metalloproteinases : relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
11Matrix metalloproteinases tissue inhibitors of metalloproteinases:relationship between changes in proteolytic determinants of matrix composition and Structural,functional,and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
12Sea anemone toxins as templates for the design of immunosuppressant drugs显示文摘Kern WR Pennington MW Norton RS 1999Perspect Drug Discov Des1999,1516,1:1
13Matrix metallopro teinases/tissue inhibitors of metalloproteinases: Relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
14Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease显示文摘Ahmed SH Clark LL Pennington WR 2006Circulation2006,113,17:1
15Effects of age on Plasma matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs)显示文摘Bonnema DD Webb CS Pennington WR 2007Card Fail2007,13,:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费